Conference: Partnering to Achieve Successful Development and Scale-Up of Cell Therapies

Conference: Partnering to Achieve Successful Development and Scale-Up of Cell Therapies

The Project Farma team is thrilled to have been invited to a prestigious speaking engagement at a half-day event led by Catalent at JLABS at Texas Medical Center. 

This half-day program featuring key opinion leaders in the field aims to explore the crucial considerations throughout the entire development process, as well as the integration of analytical strategies with process development. Additionally, the experts will share their insights on how to build effective partnerships and outsourcing strategies, which can help mitigate risks in the development process, ensuring a successful IND submission.

Johnson & Johnson Innovation – JLABS is a global life science network for innovation, providing startups with access to capital-efficient lab space and resources, including expertise, community, industry connections and entrepreneurial programs. JLABS @ TMC is a 34000-square-foot coworking lab space located in Houston, TX. The science incubator offers common, wet lab, and office space for biotech startup companies and alumni companies.

Abstract

  • Tackling the complexities of manufacturing cell therapies in compliance with current Good Manufacturing Practices (cGMP).
  • Essential considerations in process and analytical assay development for cell therapy products.
  • Keeping up with the ever-evolving regulatory landscape.
  • Explore how to leverage partnerships and outsourcing arrangements to mitigate risks and support the successful submission of INDs.

Click here to register today!